Dupont Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Dupont Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,700	Closed	-$502K	–	729
2015 Q3	$502K	Buy	+6,700	New	+$500K	0.01%	536

Dupont Capital Management's KYTH Position: Q4 2015 in Review

Dupont Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 6,700 shares — an estimated $502K sold.

Dupont Capital Management first reported a position in KYTH in Q3 2015 and held it in 1 quarter. The position peaked at $502K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Dupont Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Dupont Capital Management sold 6,700 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $502K.
Dupont Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015 and held it in 1 quarter.
Dupont Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $502K in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Dupont Capital Management's 13F filing for Q4 2015, filed 29 Jan 2016.